HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $115,000 | -34.3% | 23,200 | 0.0% | 0.00% | – |
Q4 2021 | $175,000 | -15.0% | 23,200 | -11.1% | 0.00% | – |
Q3 2021 | $206,000 | -43.1% | 26,100 | 0.0% | 0.00% | – |
Q2 2021 | $362,000 | +13.1% | 26,100 | +70.6% | 0.00% | – |
Q1 2021 | $320,000 | +7.0% | 15,300 | -15.0% | 0.00% | – |
Q4 2020 | $299,000 | -2.3% | 18,000 | 0.0% | 0.00% | – |
Q3 2020 | $306,000 | +10.9% | 18,000 | +8.4% | 0.00% | – |
Q2 2020 | $276,000 | – | 16,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |